These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12753878)

  • 1. Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.
    Ladabaum U; Scheiman JM; Fendrick AM
    Am J Med; 2003 May; 114(7):546-54. PubMed ID: 12753878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis.
    Arguedas MR; Heudebert GR; Wilcox CM
    Aliment Pharmacol Ther; 2001 May; 15(5):631-8. PubMed ID: 11328256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics of coxib therapy.
    Cantor SB
    J Pain Symptom Manage; 2002 Jul; 24(1 Suppl):S28-37. PubMed ID: 12204485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.
    Spiegel BM; Targownik L; Dulai GS; Gralnek IM
    Ann Intern Med; 2003 May; 138(10):795-806. PubMed ID: 12755551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
    Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
    Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis.
    Bae SC; Corzillius M; Kuntz KM; Liang MH
    Rheumatology (Oxford); 2003 Jan; 42(1):46-53. PubMed ID: 12509612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.
    Ladabaum U; Ferrandez A; Lanas A
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2765-76. PubMed ID: 20810603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of screening the average-risk population for colorectal cancer.
    Provenzale D
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.
    Javadinasab H; Daroudi R; Salimzadeh H; Delavari A; Vezvaie P; Malekzadeh R
    Arch Iran Med; 2017 Sep; 20(9):564-571. PubMed ID: 29048918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis.
    Lewis JD; Brown A; Localio AR; Schwartz JS
    Ann Intern Med; 2002 Jan; 136(2):99-110. PubMed ID: 11790061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese: a cost-effectiveness analysis.
    Wang ZH; Gao QY; Fang JY
    Asian Pac J Cancer Prev; 2012; 13(5):1761-6. PubMed ID: 22901118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markov's modeling for screening strategies for colorectal cancer.
    Barouni M; Larizadeh MH; Sabermahani A; Ghaderi H
    Asian Pac J Cancer Prev; 2012; 13(10):5125-9. PubMed ID: 23244122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of screening for colorectal cancer.
    Telford JJ; Levy AR; Sambrook JC; Zou D; Enns RA
    CMAJ; 2010 Sep; 182(12):1307-13. PubMed ID: 20624866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.
    Suleiman S; Rex DK; Sonnenberg A
    Gastroenterology; 2002 Jan; 122(1):78-84. PubMed ID: 11781283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
    Pence BC; Belasco EJ; Lyford CP
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective.
    Marshall JK; Pellissier JM; Attard CL; Kong SX; Marentette MA
    Pharmacoeconomics; 2001; 19(10):1039-49. PubMed ID: 11735672
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.